Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity.

Rossin A, Miloro G, Hueber AO.

Cancers (Basel). 2019 May 8;11(5). pii: E639. doi: 10.3390/cancers11050639. Review.

2.

Cell polarity and adherens junction formation inhibit epithelial Fas cell death receptor signaling.

Gagnoux-Palacios L, Awina H, Audebert S, Rossin A, Mondin M, Borgese F, Planas-Botey C, Mettouchi A, Borg JP, Hueber AO.

J Cell Biol. 2018 Nov 5;217(11):3839-3852. doi: 10.1083/jcb.201805071. Epub 2018 Sep 21.

3.
4.

Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner.

Hancz D, Szabo A, Molnar T, Varga Z, Hancz A, Gregus A, Hueber AO, Rajnavolgyi E, Koncz G.

Immunol Lett. 2018 Jan;193:42-50. doi: 10.1016/j.imlet.2017.11.007. Epub 2017 Nov 23.

PMID:
29175315
5.

The Btk-dependent PIP5K1γ lipid kinase activation by Fas counteracts FasL-induced cell death.

Rossin A, Lounnas N, Durivault J, Miloro G, Gagnoux-Palacios L, Hueber AO.

Apoptosis. 2017 Nov;22(11):1344-1352. doi: 10.1007/s10495-017-1415-x.

PMID:
28879546
6.

Detection of S-Acylated CD95 by Acyl-Biotin Exchange.

Rossin A, Hueber AO.

Methods Mol Biol. 2017;1557:189-198. doi: 10.1007/978-1-4939-6780-3_17.

PMID:
28078593
7.

Site-Specific Detection of Tyrosine Phosphorylated CD95 Following Protein Separation by Conventional and Phospho-Protein Affinity SDS-PAGE.

Chakrabandhu K, Huault S, Hueber AO.

Methods Mol Biol. 2017;1557:173-188. doi: 10.1007/978-1-4939-6780-3_16.

PMID:
28078592
8.
9.

An Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human Cancers.

Chakrabandhu K, Huault S, Durivault J, Lang K, Ta Ngoc L, Bole A, Doma E, Dérijard B, Gérard JP, Pierres M, Hueber AO.

PLoS Biol. 2016 Mar 4;14(3):e1002401. doi: 10.1371/journal.pbio.1002401. eCollection 2016 Mar.

10.

Dominant negative FADD dissipates the proapoptotic signalosome of the unfolded protein response in diabetic embryopathy.

Wang F, Weng H, Quon MJ, Yu J, Wang JY, Hueber AO, Yang P.

Am J Physiol Endocrinol Metab. 2015 Nov 15;309(10):E861-73. doi: 10.1152/ajpendo.00215.2015. Epub 2015 Sep 29.

11.

Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside.

Dorvignit D, García-Martínez L, Rossin A, Sosa K, Viera J, Hernández T, Mateo C, Hueber AO, Mesa C, López-Requena A.

Immunobiology. 2015 Dec;220(12):1343-50. doi: 10.1016/j.imbio.2015.07.008. Epub 2015 Jul 17.

PMID:
26224247
12.

The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth.

Andersen DS, Colombani J, Palmerini V, Chakrabandhu K, Boone E, Röthlisberger M, Toggweiler J, Basler K, Mapelli M, Hueber AO, Léopold P.

Nature. 2015 Jun 25;522(7557):482-6. doi: 10.1038/nature14298. Epub 2015 Apr 15.

PMID:
25874673
13.

Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death.

Zhu L, Derijard B, Chakrabandhu K, Wang BS, Chen HZ, Hueber AO.

Cancer Lett. 2014 Nov 28;354(2):355-64. doi: 10.1016/j.canlet.2014.08.038. Epub 2014 Sep 6.

PMID:
25199763
14.

Vesicles released by activated T cells induce both Fas-mediated RIP-dependent apoptotic and Fas-independent nonapoptotic cell deaths.

Koncz G, Hancz A, Chakrabandhu K, Gogolák P, Kerekes K, Rajnavölgyi E, Hueber AO.

J Immunol. 2012 Sep 15;189(6):2815-23. doi: 10.4049/jimmunol.1102827. Epub 2012 Aug 13.

15.

The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.

Koncz G, Hueber AO.

Front Immunol. 2012 Jul 25;3:207. doi: 10.3389/fimmu.2012.00207. eCollection 2012.

16.

Imatinib sensitizes T-cell lymphocytes from chronic myeloid leukemia patients to FasL-induced cell death: a brief communication.

Legros L, Ebran N, Stebe E, Rousselot P, Rea D, Cassuto JP, Mahon FX, Hueber AO.

J Immunother. 2012 Feb-Mar;35(2):154-8. doi: 10.1097/CJI.0b013e318243f238.

PMID:
22306903
17.

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level.

Legros L, Slama B, Karsenti JM, Vey N, Natarajan-Amé S, Watel E, Richard B, Bouabdallah K, Mannone L, Benchetrit M, Touitou I, Huault S, Durivault J, Ambroseti D, Hueber AO, Fenaux P, Dreyfus F; Groupe Francophone des Myélodysplasies.

Ann Hematol. 2012 Jan;91(1):39-46. doi: 10.1007/s00277-011-1242-z. Epub 2011 May 7.

PMID:
21553011
18.

Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.

Lückerath K, Kirkin V, Melzer IM, Thalheimer FB, Siele D, Milani W, Adler T, Aguilar-Pimentel A, Horsch M, Michel G, Beckers J, Busch DH, Ollert M, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Staal FJ, Rajalingam K, Hueber AO, Strobl LJ, Zimber-Strobl U, Zörnig M.

Blood. 2011 Jan 13;117(2):519-29. doi: 10.1182/blood-2010-07-292722. Epub 2010 Oct 22.

19.

Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death.

Rossin A, Kral R, Lounnas N, Chakrabandhu K, Mailfert S, Marguet D, Hueber AO.

Exp Cell Res. 2010 May 15;316(9):1513-22. doi: 10.1016/j.yexcr.2010.03.002. Epub 2010 Mar 16.

PMID:
20298688
20.

A novel role of microtubular cytoskeleton in the dynamics of caspase-dependent Fas/CD95 death receptor complexes during apoptosis.

Doma E, Chakrabandhu K, Hueber AO.

FEBS Lett. 2010 Mar 5;584(5):1033-40. doi: 10.1016/j.febslet.2010.01.059. Epub 2010 Feb 4.

Supplemental Content

Loading ...
Support Center